Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

484
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
484
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

3.7K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.7K
Menses Phase01:18

Menses Phase

824
The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
824
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

538
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
538
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

291
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
291
Analgesia and Pain Management01:25

Analgesia and Pain Management

1.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis C virus detection and management after implementation of universal screening in pregnancy.

AJOG global reports·2024
Same author

Complex Feline Disease Mapping Using a Dense Genotyping Array.

Frontiers in veterinary science·2022
Same author

In Reply.

Obstetrics and gynecology·2021
Same author

Desire for and barriers to obtaining effective contraception among women experiencing homelessness.

Contraception and reproductive medicine·2020
Same author

Delivering Emotions.

JAMA·2017
Same author

A novel iterative mixed model to remap three complex orthopedic traits in dogs.

PloS one·2017

Related Experiment Video

Updated: Dec 6, 2025

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

932

Primary Dysmenorrhea: Diagnosis and Therapy.

Elizabeth Ferries-Rowe1, Elizabeth Corey, Johanna S Archer

  • 1Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana.

Obstetrics and Gynecology
|October 8, 2020
PubMed
Summary

Primary dysmenorrhea, or menstrual pain without a cause, affects many women. Effective treatments include nonsteroidal anti-inflammatory drugs and hormonal therapy, prioritizing shared decision-making for best results.

More Related Videos

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

1.8K
Author Spotlight: Demonstrating Therapeutic Effect of Automated Zhuang Medicine Line Moxibustion Simulator
04:35

Author Spotlight: Demonstrating Therapeutic Effect of Automated Zhuang Medicine Line Moxibustion Simulator

Published on: January 19, 2024

1.3K

Related Experiment Videos

Last Updated: Dec 6, 2025

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

932
Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

1.8K
Author Spotlight: Demonstrating Therapeutic Effect of Automated Zhuang Medicine Line Moxibustion Simulator
04:35

Author Spotlight: Demonstrating Therapeutic Effect of Automated Zhuang Medicine Line Moxibustion Simulator

Published on: January 19, 2024

1.3K

Area of Science:

  • Gynecology
  • Pain Management
  • Women's Health

Background:

  • Primary dysmenorrhea is a common condition characterized by menstrual pain without an identifiable pelvic pathology.
  • It significantly impacts women's quality of life and daily functioning.
  • The pathophysiology involves increased prostaglandins (PGs) from the cyclooxygenase pathway, leading to uterine contractions and pain.

Purpose of the Study:

  • To review the pathophysiology and management of primary dysmenorrhea.
  • To highlight effective empiric treatment options and the importance of shared decision-making.

Main Methods:

  • Literature review of primary dysmenorrhea pathophysiology and treatment options.
  • Analysis of evidence supporting various therapeutic modalities.

Main Results:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) and contraceptive hormonal therapy are highly effective empiric treatments.
  • Shared decision-making is crucial for patient compliance and satisfaction.
  • Alternative treatments have less convincing supporting literature.

Conclusions:

  • Empiric treatment for primary dysmenorrhea can commence without further testing for typical cases.
  • NSAIDs and hormonal therapies are recommended first-line treatments.
  • Physicians should evaluate for secondary causes if empiric treatments fail.